Arrakis Therapeutics

Roche is to collaborate with Ascidian Therapeutics to discover and develop novel RNA exon editing therapeutics targeting neurological diseases, in a deal that could be worth up to $1.8bn. The Bosto

Remix Therapeutics has added a second large pharma player to its list of partners in just under two years, while the partner, Roche Holding AG , has expanded its presence in the growing field of RNA

Canaan Partners will invest $650m in health care and technology start-ups as part of a new, oversubscribed fund called Canaan XIII, the VC firm announced on 6 April. About 35% of the money, which will

Barbara Lueckel, Roche Holding AG ’s head of research technologies, said in an interview with Scrip that the primary change in dealmaking due to the ongoing turmoil in global financial markets is t